AbCellera Biologics Inc.
|
-0.51 USD
|
-7.843%
|
Alkermes plc
|
2.14 USD
|
125.701%
|
Agenus Inc.
|
-13.75 USD
|
96.0%
|
Aptorum Group Limited
|
-0.62 USD
|
11.29%
|
Ardelyx, Inc.
|
-0.30 USD
|
-83.333%
|
Dyadic International, Inc.
|
-0.24 USD
|
-129.167%
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
-1406.849%
|
Lantern Pharma Inc.
|
-1.47 USD
|
62.585%
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
84.594%
|
Novavax, Inc.
|
-5.41 USD
|
89.834%
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
58.333%
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
70.27%
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
99.469%
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
-19.565%
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
88.347%
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
97.249%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
56.0%
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
58.955%
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
90.534%
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
71.204%
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
99.404%
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
-22.222%
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
-3.774%
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
79.401%
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
84.375%
|
AlloVir, Inc.
|
-1.83 USD
|
69.945%
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
71.204%
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
80.144%
|
Bicycle Therapeutics plc
|
-5.08 USD
|
89.173%
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
91.057%
|
ChromaDex Corporation
|
-0.07 USD
|
-734.598%
|
Chimerix, Inc.
|
-0.93 USD
|
40.86%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
94.665%
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
60.145%
|
CRISPR Therapeutics AG
|
-1.94 USD
|
71.649%
|
Precision BioSciences, Inc.
|
-15.96 USD
|
96.554%
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
66.463%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
93.506%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
93.506%
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
93.627%
|
ImmuCell Corporation
|
-0.75 USD
|
26.667%
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
71.939%
|
Immix Biopharma, Inc.
|
-0.89 USD
|
38.202%
|
Incyte Corporation
|
2.67 USD
|
120.599%
|
Innoviva, Inc.
|
2.92 USD
|
118.836%
|
IO Biotech, Inc.
|
-1.98 USD
|
72.222%
|
Jaguar Health, Inc.
|
-107.42 USD
|
99.488%
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
89.423%
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
118.212%
|
ContextLogic Inc.
|
-13.36 USD
|
95.883%
|
MiMedx Group, Inc.
|
0.48 USD
|
214.583%
|
MEI Pharma, Inc.
|
2.67 USD
|
120.599%
|
NextCure, Inc.
|
-2.25 USD
|
75.556%
|
Onconetix, Inc.
|
-2.19 USD
|
74.886%
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
95.905%
|
Opthea Limited
|
-0.35 USD
|
-57.143%
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
92.994%
|
Vaxcyte, Inc.
|
-4.14 USD
|
86.715%
|
PDS Biotechnology Corporation
|
-1.39 USD
|
60.432%
|
Precigen, Inc.
|
-0.39 USD
|
-41.026%
|
Pharming Group N.V.
|
-0.16 USD
|
-243.75%
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
86.005%
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
97.477%
|
PureTech Health plc
|
-2.38 USD
|
76.891%
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
61.806%
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
81.1%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
56.0%
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
62.838%
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
45.545%
|
Acelyrin, Inc.
|
-5.43 USD
|
89.871%
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
-14373.684%
|
Summit Therapeutics Inc.
|
-0.99 USD
|
44.444%
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
54.918%
|
Senti Biosciences, Inc.
|
-16.01 USD
|
96.565%
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
76.891%
|
Elevation Oncology, Inc.
|
-1.34 USD
|
58.955%
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
97.497%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
-25.0%
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
-175.0%
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
63.816%
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
82.972%
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
-1.852%
|
Seer, Inc.
|
-1.35 USD
|
59.259%
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
62.838%
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
77.459%
|
ESSA Pharma Inc.
|
-0.60 USD
|
8.333%
|
GlycoMimetics, Inc.
|
-0.58 USD
|
5.172%
|
GT Biopharma, Inc.
|
-5.64 USD
|
90.248%
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
89.258%
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
-96.429%
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
182.09%
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
76.987%
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
62.838%
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
96.264%
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
59.854%
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
75.0%
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
58.333%
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
81.164%
|
Aptose Biosciences Inc.
|
-7.58 USD
|
92.744%
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
99.95%
|
Soligenix, Inc.
|
-12.66 USD
|
95.656%
|
Century Therapeutics, Inc.
|
-2.30 USD
|
76.087%
|
Kura Oncology, Inc.
|
-2.08 USD
|
73.558%
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
59.559%
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
60.145%
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
-1991.255%
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
-7042.857%
|
Autolus Therapeutics plc
|
-1.20 USD
|
54.167%
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
72.362%
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
69.78%
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
86.52%
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
64.744%
|
GRI Bio, Inc.
|
-28.25 USD
|
98.053%
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
79.705%
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
67.262%
|
IGM Biosciences, Inc.
|
-4.71 USD
|
88.323%
|
INmune Bio, Inc.
|
-1.67 USD
|
67.066%
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
31.25%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
92.801%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
95.652%
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
98.851%
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
60.432%
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
3.509%
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
99.156%
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
78.261%
|
Verastem, Inc.
|
-3.96 USD
|
86.111%
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
78.261%
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
80.0%
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
99.749%
|
Histogen Inc.
|
-3.46 USD
|
84.104%
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
86.076%
|
Surrozen, Inc.
|
-21.33 USD
|
97.421%
|
Organovo Holdings, Inc.
|
-1.60 USD
|
65.625%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
79.323%
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
25.676%
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
100.0%
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
72.772%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
11.29%
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
64.968%
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
95.536%
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
50.893%
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
77.733%
|
Apollomics, Inc.
|
-2.32 USD
|
76.293%
|
Amarin Corporation plc
|
-0.15 USD
|
-266.667%
|
Mesoblast Limited
|
-0.89 USD
|
38.202%
|
Turnstone Biologics Corp.
|
-4.77 USD
|
88.47%
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
78.175%
|
Synaptogenix, Inc.
|
-29.56 USD
|
98.139%
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
-243.75%
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
-1.852%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-89.655%
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
5.172%
|
Exelixis, Inc.
|
0.65 USD
|
184.615%
|
Better Therapeutics, Inc.
|
-1.69 USD
|
67.456%
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
79.245%
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
87.64%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-71.875%
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
98.631%
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
66.463%
|
Gritstone bio, Inc.
|
-1.20 USD
|
54.167%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
91.1%
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
89.681%
|
Avid Bioservices, Inc.
|
-2.23 USD
|
75.336%
|
Insmed Incorporated
|
-5.34 USD
|
89.7%
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
95.759%
|
MediWound Ltd.
|
-0.75 USD
|
26.667%
|
OmniAb, Inc.
|
-0.51 USD
|
-7.843%
|
Alector, Inc.
|
-1.56 USD
|
64.744%
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
38.202%
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
80.144%
|
Zai Lab Limited
|
-3.46 USD
|
84.104%
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
85.64%
|
Aura Biosciences, Inc.
|
-1.93 USD
|
71.503%
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
40.86%
|
Immunic, Inc.
|
-2.11 USD
|
73.934%
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
88.095%
|
Veracyte, Inc.
|
-1.02 USD
|
46.078%
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
45.545%
|
FibroGen, Inc.
|
-2.92 USD
|
81.164%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
98.184%
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
89.89%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
96.968%
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
107.914%
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
97.944%
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
175.342%
|
TG Therapeutics, Inc.
|
0.09 USD
|
715.901%
|
Galecto, Inc.
|
-36.08 USD
|
98.476%
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
93.073%
|
Fortrea Holdings Inc.
|
-0.04 USD
|
-1336.031%
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
84.012%
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
99.122%
|
XBiotech Inc.
|
-0.81 USD
|
32.099%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
91.1%
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
56.349%
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
76.496%
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
-12.245%
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
45.0%
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
93.333%
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
69.78%
|
Vaxxinity, Inc.
|
-0.45 USD
|
-22.222%
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
53.39%
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
67.836%
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
98.706%
|
NexImmune, Inc.
|
-30.82 USD
|
98.215%
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
85.372%
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
71.503%
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
101.484%
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
73.301%
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
81.967%
|
Ainos, Inc.
|
-3.36 USD
|
83.631%
|
Pluri Inc.
|
-3.99 USD
|
86.216%
|
Prothena Corporation plc
|
-2.76 USD
|
80.072%
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
3.509%
|
Celularity Inc.
|
-11.02 USD
|
95.009%
|
Rallybio Corporation
|
-1.84 USD
|
70.109%
|
Cue Biopharma, Inc.
|
-1.11 USD
|
50.45%
|
MeiraGTx Holdings plc
|
-1.49 USD
|
63.087%
|
Omeros Corporation
|
-1.88 USD
|
70.745%
|
Humacyte, Inc.
|
-1.07 USD
|
48.598%
|
Immunocore Holdings plc
|
-1.13 USD
|
51.327%
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
70.43%
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
89.524%
|
Blueprint Medicines Corporation
|
-8.37 USD
|
93.429%
|
CalciMedica, Inc.
|
-7.65 USD
|
92.81%
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
66.667%
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
79.087%
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
72.362%
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
62.329%
|
Pulmatrix, Inc.
|
-3.87 USD
|
85.788%
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
92.098%
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
74.178%
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
89.852%
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
92.424%
|
Cytokinetics, Incorporated
|
-5.45 USD
|
89.908%
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
96.697%
|
Nutriband Inc.
|
-0.69 USD
|
20.29%
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
84.594%
|
Vor Biopharma Inc.
|
-1.75 USD
|
68.571%
|
Roivant Sciences Ltd.
|
5.55 USD
|
109.91%
|
Evogene Ltd.
|
-5.23 USD
|
89.484%
|
ProKidney Corp.
|
-0.57 USD
|
3.509%
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
61.268%
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
76.087%
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
86.076%
|
CorMedix Inc.
|
-0.91 USD
|
39.56%
|
BioLineRx Ltd.
|
-0.94 USD
|
41.489%
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
49.074%
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
25.676%
|
Atai Life Sciences N.V.
|
-0.25 USD
|
-120.0%
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
34.524%
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
80.836%
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
87.696%
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
79.323%
|
MediciNova, Inc.
|
-0.17 USD
|
-223.529%
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
97.057%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
16.667%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
94.618%
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
89.564%
|
Biomea Fusion, Inc.
|
-3.44 USD
|
84.012%
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
93.429%
|
Mereo BioPharma Group plc
|
-0.04 USD
|
-1130.425%
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
85.095%
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
81.544%
|
Absci Corporation
|
-1.20 USD
|
54.167%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
86.181%
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
78.682%
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
86.076%
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
375.0%
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
83.333%
|
Allakos Inc.
|
-2.14 USD
|
74.299%
|
Imunon, Inc.
|
-2.16 USD
|
74.537%
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
65.409%
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
153.922%
|
BioAtla, Inc.
|
-2.58 USD
|
78.682%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-71.875%
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
98.365%
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
73.684%
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
34.524%
|
XOMA Corporation
|
-4.04 USD
|
86.386%
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
60.714%
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
74.886%
|
aTyr Pharma, Inc.
|
-0.94 USD
|
41.489%
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
84.375%
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
80.969%
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
89.642%
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
57.692%
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
78.346%
|
Akari Therapeutics, Plc
|
-2.04 USD
|
73.039%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-137400.0%
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
125.822%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
45.545%
|
UroGen Pharma Ltd.
|
-3.55 USD
|
84.507%
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
69.101%
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
88.043%
|
Orgenesis Inc.
|
-1.91 USD
|
71.204%
|
Entera Bio Ltd.
|
-0.31 USD
|
-77.419%
|
GH Research PLC
|
-0.68 USD
|
19.118%
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
78.682%
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
97.82%
|
Xencor, Inc.
|
-2.08 USD
|
73.558%
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
42.105%
|
Replimune Group, Inc.
|
-3.24 USD
|
83.025%
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
33.735%
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
1358.581%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
45.545%
|
Portage Biotech Inc.
|
-3.70 USD
|
85.135%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
16.667%
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
74.299%
|
OncoCyte Corporation
|
-3.75 USD
|
85.333%
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
77.642%
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
93.514%
|
Purple Biotech Ltd.
|
-0.09 USD
|
-512.472%
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
11.29%
|
scPharmaceuticals Inc.
|
-1.42 USD
|
61.268%
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
61.268%
|
HilleVax, Inc.
|
-3.04 USD
|
81.908%
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
33.735%
|
Tharimmune, Inc.
|
-107.08 USD
|
99.486%
|
Genprex, Inc.
|
-22.58 USD
|
97.564%
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
63.087%
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
-129.167%
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
-16566.667%
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
-96.429%
|
OKYO Pharma Limited
|
-0.00 USD
|
-91566.667%
|
Savara Inc.
|
-0.33 USD
|
-66.667%
|
Curis, Inc.
|
-8.96 USD
|
93.862%
|
Daré Bioscience, Inc.
|
-4.15 USD
|
86.747%
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
62.329%
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
92.578%
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
63.333%
|
BeiGene, Ltd.
|
-8.45 USD
|
93.491%
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
97.431%
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
85.751%
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
60.432%
|
Erasca, Inc.
|
-0.83 USD
|
33.735%
|
bluebird bio, Inc.
|
-1.93 USD
|
71.503%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
52.174%
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
161.798%
|
DBV Technologies S.A.
|
-0.76 USD
|
27.632%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
52.174%
|
Moderna, Inc.
|
-12.34 USD
|
95.543%
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
70.899%
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
42.708%
|
Molecular Templates, Inc.
|
-1.80 USD
|
69.444%
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
79.927%
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
63.333%
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
79.087%
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
55.645%
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
81.164%
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
77.273%
|
MacroGenics, Inc.
|
-0.15 USD
|
-266.667%
|
RenovoRx, Inc.
|
-0.99 USD
|
44.444%
|
Adicet Bio, Inc.
|
-3.31 USD
|
83.384%
|
Prime Medicine, Inc.
|
-2.18 USD
|
74.771%
|
Aditxt, Inc.
|
-4326.64 USD
|
99.987%
|
Adagene Inc.
|
-0.44 USD
|
-25.0%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-161.905%
|
Quantum-Si incorporated
|
-0.68 USD
|
19.118%
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
38.889%
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
52.174%
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
117.857%
|
SciSparc Ltd.
|
-14.43 USD
|
96.188%
|
Vericel Corporation
|
-0.07 USD
|
-722.123%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-3.774%
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
88.069%
|
Generation Bio Co.
|
-1.96 USD
|
71.939%
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
77.273%
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
70.745%
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
85.45%
|
Invivyd, Inc.
|
-1.81 USD
|
69.613%
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
80.287%
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
94.295%
|
Spero Therapeutics, Inc.
|
0.43 USD
|
227.907%
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
84.241%
|
2seventy bio, Inc.
|
-4.42 USD
|
87.557%
|
ADMA Biologics, Inc.
|
-0.13 USD
|
-323.077%
|
Clene Inc.
|
-9.43 USD
|
94.168%
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
33.735%
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
75.225%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
94.618%
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
65.19%
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
-150.0%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
140.441%
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
83.232%
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
98.819%
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
85.294%
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
88.017%
|
Evaxion Biotech A/S
|
-8.11 USD
|
93.218%
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
49.541%
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
82.372%
|
Trevena, Inc.
|
-54.51 USD
|
98.991%
|
Surrozen, Inc.
|
-21.33 USD
|
97.421%
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
66.049%
|
Cingulate Inc.
|
-311.99 USD
|
99.824%
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
98.17%
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
79.63%
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
98.231%
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
56.693%
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
-48.649%
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
49.074%
|
Clearmind Medicine Inc.
|
-59.18 USD
|
99.071%
|
Kronos Bio, Inc.
|
-1.95 USD
|
71.795%
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
69.945%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-41.026%
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
39.56%
|
Statera Biopharma, Inc.
|
-4.97 USD
|
88.934%
|
ImmunityBio, Inc.
|
-1.15 USD
|
52.174%
|
Korro Bio, Inc.
|
-53.08 USD
|
98.964%
|
Kineta, Inc.
|
-1.28 USD
|
57.031%
|
BioVie Inc.
|
-7.30 USD
|
92.466%
|
Codexis, Inc.
|
-1.12 USD
|
50.893%
|
Celularity Inc.
|
-11.02 USD
|
95.009%
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
85.095%
|
Celcuity Inc.
|
-2.69 USD
|
79.554%
|
Virax Biolabs Group Limited
|
-3.36 USD
|
83.631%
|
Cibus, Inc.
|
-25.95 USD
|
97.881%
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
-34275.0%
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
96.64%
|
IN8bio, Inc.
|
-1.00 USD
|
45.0%
|
Kodiak Sciences Inc.
|
-4.97 USD
|
88.934%
|
Annexon, Inc.
|
-1.77 USD
|
68.927%
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
95.267%
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
95.889%
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
99.516%
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
78.516%
|
Eyenovia, Inc.
|
-0.66 USD
|
16.667%
|
Puma Biotechnology, Inc.
|
0.46 USD
|
219.565%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-508.407%
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
80.216%
|
Arcellx, Inc.
|
-1.47 USD
|
62.585%
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
40.86%
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
91.379%
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
65.19%
|
Moolec Science SA
|
-1.50 USD
|
63.333%
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
49.074%
|
Geron Corporation
|
-0.32 USD
|
-71.875%
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
64.968%
|
Royalty Pharma plc
|
3.41 USD
|
116.129%
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
66.258%
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
20.29%
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
95.359%
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
62.838%
|
Humacyte, Inc.
|
-1.07 USD
|
48.598%
|
Structure Therapeutics Inc.
|
-2.44 USD
|
77.459%
|
89bio, Inc.
|
-2.00 USD
|
72.5%
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
61.806%
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
99.253%
|
Genelux Corporation
|
-1.16 USD
|
52.586%
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
-89.655%
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
31.25%
|
Notable Labs, Ltd.
|
-5.03 USD
|
89.066%
|
Liquidia Corporation
|
-1.21 USD
|
54.545%
|
Mustang Bio, Inc.
|
-6.00 USD
|
90.833%
|
Immunovant, Inc.
|
-1.88 USD
|
70.745%
|
Quantum-Si incorporated
|
-0.68 USD
|
19.118%
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
-25.0%
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
8.333%
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
75.556%
|
Acasti Pharma Inc.
|
-1.35 USD
|
59.259%
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
15.385%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
95.652%
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
79.853%
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
-37.5%
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
77.642%
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
71.204%
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
76.695%
|
PepGen Inc.
|
-3.30 USD
|
83.333%
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
96.35%
|
United Therapeutics Corporation
|
21.04 USD
|
102.614%
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
61.538%
|
Solid Biosciences Inc.
|
-4.83 USD
|
88.613%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-89.655%
|
Immuneering Corporation
|
-1.88 USD
|
70.745%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
79.323%
|
Silo Pharma, Inc.
|
-1.20 USD
|
54.167%
|
Belite Bio, Inc
|
-1.19 USD
|
53.782%
|
XOMA Corporation
|
-4.04 USD
|
86.386%
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
3.509%
|
Bionomics Limited
|
-1.02 USD
|
46.078%
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
-16076.471%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-30.952%
|
uniQure N.V.
|
-6.47 USD
|
91.499%
|
Cassava Sciences, Inc.
|
-2.32 USD
|
76.293%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-161.905%
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
59.854%
|
Forte Biosciences, Inc.
|
-24.92 USD
|
97.793%
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
-71.875%
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
64.744%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-508.407%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
98.184%
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
6.78%
|
Altimmune, Inc.
|
-1.66 USD
|
66.867%
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
-7.843%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-30.952%
|
Compugen Ltd.
|
-0.21 USD
|
-161.905%
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
57.692%
|
Benitec Biopharma Inc.
|
-5.36 USD
|
89.739%
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
98.88%
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
89.777%
|
Zura Bio Limited
|
-2.09 USD
|
73.684%
|
PolyPid Ltd.
|
-16.99 USD
|
96.763%
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
83.918%
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
89.777%
|
Instil Bio, Inc.
|
-24.00 USD
|
97.708%
|
argenx SE
|
-5.16 USD
|
89.341%
|
Immunome, Inc.
|
-5.38 USD
|
89.777%
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
-66.667%
|
Verona Pharma plc
|
-0.54 USD
|
-1.852%
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
87.805%
|
Shattuck Labs, Inc.
|
-2.05 USD
|
73.171%
|
CervoMed Inc.
|
-0.82 USD
|
32.927%
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
96.405%
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
87.028%
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
93.491%
|
Moolec Science SA
|
-1.50 USD
|
63.333%
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
93.201%
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
90.969%
|
AnaptysBio, Inc.
|
-6.08 USD
|
90.954%
|
Design Therapeutics, Inc.
|
-1.19 USD
|
53.782%
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
86.181%
|
NeurAxis, Inc.
|
-4.03 USD
|
86.352%
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
92.885%
|
Lumos Pharma, Inc.
|
-4.18 USD
|
86.842%
|
Achilles Therapeutics plc
|
-1.74 USD
|
68.391%
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
87.805%
|
180 Life Sciences Corp.
|
-52.60 USD
|
98.954%
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
180.882%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-41.026%
|
Nutriband Inc.
|
-0.69 USD
|
20.29%
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
71.939%
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
96.486%
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
72.222%
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
58.647%
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
24.658%
|
Palisade Bio, Inc.
|
-27.01 USD
|
97.964%
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
93.799%
|
Beam Therapeutics Inc.
|
-1.72 USD
|
68.023%
|
Neurogene Inc.
|
-2.83 USD
|
80.565%
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
86.25%
|
AEON Biopharma, Inc.
|
- USD
|
Infinity%
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
76.891%
|
Sesen Bio, Inc.
|
-1.99 USD
|
72.362%
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
72.637%
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
97.732%
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
70.899%
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
42.708%
|
Athira Pharma, Inc.
|
-3.10 USD
|
82.258%
|
Vaccinex, Inc.
|
-43.68 USD
|
98.741%
|
HCW Biologics Inc.
|
-0.70 USD
|
21.429%
|
XOMA Corporation
|
-4.04 USD
|
86.386%
|
Nektar Therapeutics
|
-1.45 USD
|
62.069%
|
Arvinas, Inc.
|
-6.62 USD
|
91.692%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-137400.0%
|
Merus N.V.
|
-3.00 USD
|
81.667%
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
69.444%
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
34.524%
|
Rezolute, Inc.
|
-1.33 USD
|
58.647%
|
Clene Inc.
|
-9.43 USD
|
94.168%
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
70.109%
|
BeyondSpring Inc.
|
-0.54 USD
|
-1.852%
|
Synlogic, Inc.
|
-8.81 USD
|
93.757%
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
-5239.806%
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
98.827%
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
47.619%
|
Krystal Biotech, Inc.
|
0.40 USD
|
237.5%
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
56.0%
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
89.32%
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
28.571%
|
MannKind Corporation
|
-0.04 USD
|
-1130.425%
|
Ikena Oncology, Inc.
|
-1.63 USD
|
66.258%
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
93.882%
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
60.993%
|
Gossamer Bio, Inc.
|
-1.18 USD
|
53.39%
|
CohBar, Inc.
|
-4.13 USD
|
86.683%
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
36.047%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
86.181%
|
Legend Biotech Corporation
|
-2.94 USD
|
81.293%
|
Mural Oncology plc
|
-12.43 USD
|
95.575%
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
93.011%
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
95.0%
|
Disc Medicine, Inc.
|
-3.43 USD
|
83.965%
|
Champions Oncology, Inc.
|
-0.54 USD
|
-1.852%
|
REGENXBIO Inc.
|
-6.02 USD
|
90.864%
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
88.273%
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
8.333%
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
82.315%
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
64.968%
|
Vaxart, Inc.
|
-0.57 USD
|
3.509%
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
69.444%
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
14.063%
|
Cellectis S.A.
|
-1.77 USD
|
68.927%
|
Longeveron Inc.
|
-10.22 USD
|
94.618%
|
Repare Therapeutics Inc.
|
-2.23 USD
|
75.336%
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
90.517%
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
59.854%
|
Revolution Medicines, Inc.
|
-3.86 USD
|
85.751%
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
-648.299%
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
29.487%
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
74.654%
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
79.927%
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
-71.875%
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
103.915%
|
Denali Therapeutics Inc.
|
-1.06 USD
|
48.113%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-3.774%
|
Veru Inc.
|
-1.10 USD
|
50.0%
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
1.786%
|
Cingulate Inc.
|
-311.99 USD
|
99.824%
|
Passage Bio, Inc.
|
-1.86 USD
|
70.43%
|
Context Therapeutics Inc.
|
-1.50 USD
|
63.333%
|
Exicure, Inc.
|
-2.11 USD
|
73.934%
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
76.793%
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
43.299%
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
96.691%
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
82.813%
|
Nuvalent, Inc.
|
-2.17 USD
|
74.654%
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
77.366%
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
78.764%
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
57.031%
|
OmniAb, Inc.
|
-0.51 USD
|
-7.843%
|
Anew Medical, Inc.
|
0.14 USD
|
492.857%
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
8.333%
|
Lipocine Inc.
|
-3.14 USD
|
82.484%
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
77.912%
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
-7.843%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
92.801%
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
40.86%
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
73.558%
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
93.923%
|
Ocugen, Inc.
|
-0.26 USD
|
-111.538%
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
77.459%
|
Q32 Bio Inc.
|
-35.16 USD
|
98.436%
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
-37.5%
|
Alumis Inc. Common Stock
|
-2.99 USD
|
81.605%
|
Equillium, Inc.
|
-0.38 USD
|
-44.737%
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
-549900.0%
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
30.38%
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
99.781%
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
58.647%
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
97.907%
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
68.75%
|
Dominari Holdings Inc.
|
-4.38 USD
|
87.443%
|
Edesa Biotech, Inc.
|
-2.93 USD
|
81.229%
|
vTv Therapeutics Inc.
|
-9.71 USD
|
94.336%
|
Bio-Techne Corporation
|
1.07 USD
|
151.402%
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
91.311%
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
125.346%
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
72.772%
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
58.015%
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
82.54%
|
Nkarta, Inc.
|
-2.40 USD
|
77.083%
|
BioCardia, Inc.
|
-8.19 USD
|
93.284%
|
Iterum Therapeutics plc
|
-2.96 USD
|
81.419%
|